Somnus Therapeutics Overview

  • Founded
  • 2007
  • Status
  • Out of Business
  • Employees
  • 4
  • Latest Deal Type
  • Out of Business

Somnus Therapeutics General Information


Operator of a drug development company designed to address the needs of insomnia patients. The company's drugs prevent the mid-night awakenings of the patients without next-day hangovers, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 3322 Route 22 West, Building 4
  • Suite 428
  • Branchburg, NJ 08876
  • United States
+1 (908) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Somnus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jan-2016 0000 Completed Out of Business
2. Grant 04-Nov-2010 00000 0000 Completed Startup
1. Early Stage VC (Series A) 11-Feb-2010 $15M $15M 0000 Completed Startup
To view Somnus Therapeutics’s complete valuation and funding history, request access »

Somnus Therapeutics Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00 00 00 00 00.000
To view Somnus Therapeutics’s complete cap table history, request access »

Somnus Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Gary Cupit Chief Executive Officer, Board Member and Founder
Christine Blumhardt Chief Regulatory Officer
Mary Osbakken MD Chief Medical Officer
Daniel Cabo Jr. Chief Financial Officer
You’re viewing 4 of 6 executive team members. Get the full list »

Somnus Therapeutics Board Members (5)

Name Representing Role Since
Gary Cupit Somnus Therapeutics Chief Executive Officer, Board Member and Founder 000 0000
Jack Britts Self Board Member 000 0000
You’re viewing 2 of 5 board members. Get the full list »

Somnus Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial